CD8A and neoplasm: When dendritic cells were reprogrammed via their treatment with the β-glucan curdlan, a ligand of dectin-1 to induce mucosal antitumour CD8+T cells expressing CD103, these cells were found to be more efficient than control CD8+T cell to inhibit tumour growth33.